New genetic variants could raise a woman’s risk of cervical cancer from HPV infections

Human papillomavirus (HPV) is the second most common cancer-causing virus, accounting for 690,000 cervical and other cancers each year worldwide.

Novel Therapies Show Early Promise in Advanced Gastroesophageal Cancers

Results of two early-phase trials offered a glimpse of promising new agents in the pipeline for advanced gastroesophageal cancer. In a phase II study, incorporating

November 9, 2023

The drug lobby’s lawsuit against the IRA finds a sign of life after appeals court ruling

The US Court of Appeals for the Fifth Circuit is reviving PhRMA’s legal attack on Medicare drug price negotiations. On Friday, the appeals court reversed

September 21, 2024

Study: Risk of dying from cancer depends on where you live in England

The risk of dying from the 10 forms of cancer with the largest death toll for men and women varies massively depending on the district

December 12, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.